In advanced cancer, increased inflammation leads to increased neutrophils, reduced lymphocytes, and lower albumin levels, which can suppress cancer immunity and diminish ICI efficacy, possibly explaining the lower irAE incidence in patients with reduced PNI (50). This evidence concerns the gene ALB and cancer.